Buck Institute for Research on Aging

Venture capital investors have not taken the summer off, at least not during the first few weeks of June, continuing to support mega-rounds of $100m or more for biopharmaceutical companies with novel

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

This year's venture capital total as of the third quarter shows that money raised by biopharmaceutical companies is on a rollercoaster ride in 2019, according to the latest Venture Monitor report fr

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Mustang